66th Annual Conference
Thursday, February
19
Early Bird
Open Sessions
7:15-8:15 A.M.
Session
205
Group
Therapy for Smoking Cessation Treatment
Presented under
the auspices of the AGPA Psychiatry SIG
Presenter:
David W. Brook, M.D., CGP, LFAGPA,
Professor of Psychiatry, New York University School of Medicine, New
York, New York
This presentation
will address the use of group therapy for smoking cessation
treatment. The literature will be reviewed, as will recent
psychopharmacological advances in treatment. Smoking kills 430,000
people in the U.S. each year, and causes adverse medical,
psychosocial, familial, and economic consequences. Group therapy is,
perhaps, the most useful and cost-effective method of delivering
this life-saving treatment to smokers. Participants will be able to
bring up specific issues regarding smoking and its treatment.
Learning
Objectives:
The attendee will
be able to:
1. Understand the
epidemiology and biopsychosocial aspects of smoking and its
treatment.
2. Apply the
latest methods and techniques to help smokers achieve cessation
using a group therapy approach, including CBT, contingency
management, and modified psychodynamic treatments.
3. Evaluate
psychopharmacological methods to be used to achieve smoking
cessation in group therapy, and their neurobiological bases.
Course References:
1. Brook J.S.,
Pahl K., & Brook D.W. (2008). Tobacco use and dependence. In
C.A. Essau (Ed.), Adolescent Addiction: Epidemiology, assessment, and
treatment (pp. 149-177). New York: Elsevier, Inc.
2. Carmody T.P.
(2002). Smoking cessation treatment groups. In
D.W. Brook & H.I.
Spitz (Eds.), The Group Therapy of Substance Abuse (pp. 351-368).
New York: Haworth Medical Press.
3. Carroll K.M.
(1996). Relapse prevention as a psychosocial treatment: A review of
controlled clinical trials. Experimental & Clinical
Psychopharmacology, 4 (1): 46-54.
4. Ingersoll K.S.,
& Cohen J. (2005). Combination treatment for nicotine dependence:
state of the science. Substance Use and Misuse, 40: 1923-1943. |
